Citation Impact
Citing Papers
2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
2016 Standout
Multiple Biomarkers for Risk Prediction in Chronic Heart Failure
2012
Prevalence of Left Ventricular Diastolic Dysfunction in a General Population
2009
Head-to-Head Comparison of 2 Myocardial Fibrosis Biomarkers for Long-Term Heart Failure Risk Stratification
2013
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
State of the Art: Newer Biomarkers in Heart Failure
2015
Continuous venovenous haemofiltration in neonates
2004
Pharmacologic Targeting of Hypoxia-Inducible Factors
2019 StandoutNobel
Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease
2007
NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patients
2005
An Overview and Update on Obesity and the Obesity Paradox in Cardiovascular Diseases
2018
Markers of fibrosis, inflammation, and remodeling pathways in heart failure
2014
ST2 and Prognosis in Acutely Decompensated Heart Failure: The International ST2 Consensus Panel
2015
Role of IL-33 in inflammation and disease
2011
Establishing the Diagnosis of Lung Cancer
2013 Standout
Clopidogrel with or without Omeprazole in Coronary Artery Disease
2010 Standout
Experimental Exposure to Wood-Smoke Particles in Healthy Humans: Effects on Markers of Inflammation, Coagulation, and Lipid Peroxidation
2006
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Correlation and Prognostic Utility of B-Type Natriuretic Peptide and Its Amino-Terminal Fragment in Patients With Chronic Kidney Disease
2006
Plasma pro-B-type natriuretic peptide in the general population: screening for left ventricular hypertrophy and systolic dysfunction
2006
Amino-Terminal Pro–B-Type Natriuretic Peptide Testing for the Diagnosis or Exclusion of Heart Failure in Patients with Acute Symptoms
2008
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
2007 Standout
Endocrine intervention for transsexuals
2003
Head-to-Head Comparison of Serial Soluble ST2, Growth Differentiation Factor-15, and Highly-Sensitive Troponin T Measurements in Patients With Chronic Heart Failure
2014
The Emerging Role of Galectin-3 and ST2 in Heart Failure: Practical Considerations and Pitfalls Using Novel Biomarkers
2013
Diagnostic value of pleural fluid N‐terminal pro‐brain natriuretic peptide levels in patients with cardiovascular diseases
2008
Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis
2013 Standout
Combination therapy of statin with flavonoids rich extract from chokeberry fruits enhanced reduction in cardiovascular risk markers in patients after myocardial infraction (MI)
2007
National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure
2007
Reduction in BNP Levels With Treatment of Decompensated Heart Failure and Future Clinical Events
2008
The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report
2010 Standout
Measurement of pro-brain natriuretic peptide in pleural fluid for the diagnosis of pleural effusions due to heart failure
2004
Levels of sP-selectin and hs-CRP Decrease with Dietary Intervention with Selenium and Coenzyme Q10 Combined: A Secondary Analysis of a Randomized Clinical Trial
2015 StandoutNobel
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
Use of BNP and NT-proBNP for the diagnosis of heart failure in the emergency department: a systematic review of the evidence
2014
Bariatric Surgery and Emergency Department Visits and Hospitalizations for Heart Failure Exacerbation
2016
Renal impairment, worsening renal function, and outcome in patients with heart failure: an updated meta-analysis
2013 Standout
In situ immune response and mechanisms of cell damage in central nervous system of fatal cases microcephaly by Zika virus
2018 Standout
Chronic kidney disease
2011 Standout
Prognostic Value of Baseline and Changes in Circulating Soluble ST2 Levels and the Effects of Nesiritide in Acute Decompensated Heart Failure
2015
Estimating Glomerular Filtration Rate from Serum Creatinine and Cystatin C
2012 Standout
Amino-Terminal Pro-B-Type Natriuretic Peptide and B-Type Natriuretic Peptide in the General Community
2006
Adipokines in inflammation and metabolic disease
2011 Standout
Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: A systematic review
2007
Investigation of a unilateral pleural effusion in adults: British Thoracic Society pleural disease guideline 2010
2010 Standout
Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
2021 Standout
Cardiorenal Syndrome
2008 Standout
Recommendations for Cardiac Chamber Quantification by Echocardiography in Adults: An Update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging
2015 Standout
Recommendations for the use of natriuretic peptides in acute cardiac care: A position statement from the Study Group on Biomarkers in Cardiology of the ESC Working Group on Acute Cardiac Care
2011
BNP and NT-proBNP as prognostic markers in persons with acute decompensated heart failure: a systematic review
2014
Effects of Oral Tolvaptan in Patients Hospitalized for Worsening Heart Failure<SUBTITLE>The EVEREST Outcome Trial</SUBTITLE>
2007 Standout
Direct Comparison of B-Type Natriuretic Peptide (BNP) and Amino-Terminal proBNP in a Large Population of Patients with Chronic and Symptomatic Heart Failure: The Valsartan Heart Failure (Val-HeFT) Data
2006
High-Sensitivity C-Reactive Protein in Acute Heart Failure: Insights From the ASCEND-HF Trial
2014
Overview of Epidemiology and Contribution of Obesity and Body Fat Distribution to Cardiovascular Disease: An Update
2018
The N-terminal Pro-BNP Investigation of Dyspnea in the Emergency department (PRIDE) study
2005
Effects of pantoprazole and esomeprazole on platelet inhibition by clopidogrel
2008
The role of adiponectin in the pathogenesis and treatment of non‐alcoholic fatty liver disease
2009
Natriuretic Peptide as an Adjunctive Diagnostic Test in the Acute Phase of Kawasaki Disease
2009
Congestion in Acute Heart Failure Syndromes: An Essential Target of Evaluation and Treatment
2006
Effects of Levosimendan on the Energy Balance: Preclinical and Clinical Evidence
2009
A Novel Paradigm for Heart Failure With Preserved Ejection Fraction
2013 Standout
Exercise Capacity and the Obesity Paradox in Heart Failure: The FIT (Henry Ford Exercise Testing) Project
2018
Cardiovascular biomarkers and sex: the case for women
2015
A systematic review of muscle morphology and function in intermittent claudication
2017 StandoutNobel
Biomarkers in cardiovascular disease: Beyond natriuretic peptides
2009
New and Emerging Biomarkers in Left Ventricular Systolic Dysfunction—Insight into Dilated Cardiomyopathy
2013
Prognostic Value of Midregional Pro-Adrenomedullin in Patients With Acute Myocardial Infarction
2007
Using ankle-brachial index to detect peripheral arterial disease: Prevalence and associated risk factors in a random population sample
2006
Diagnosis, Treatment, and Long-Term Management of Kawasaki Disease: A Scientific Statement for Health Professionals From the American Heart Association
2017 Standout
Plasma adiponectin and mortality in critically ill subjects with acute respiratory failure*
2010
Biomarkers in Heart Failure
2008 Standout
Renal Function, Congestive Heart Failure, and Amino-Terminal Pro-Brain Natriuretic Peptide Measurement
2005
Plasma Interleukin-10 Levels and Adverse Outcomes in Acute Coronary Syndrome
2011
Comparing serum and pleural fluid pro‐brain natriuretic peptide (NT‐proBNP) levels with pleural‐to‐serum albumin gradient for the identification of cardiac effusions misclassified by Light's criteria
2007
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts
2011
Cystatin C and NT‐proBNP, a powerful combination of biomarkers for predicting cardiovascular mortality in elderly patients with heart failure: results from a 10‐year study in primary care
2009 StandoutNobel
Dietary (Poly)phenolics in Human Health: Structures, Bioavailability, and Evidence of Protective Effects Against Chronic Diseases
2012 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure
2017 Standout
Circulating Biomarkers in Patients with Heart Failure and Preserved Ejection Fraction
2013
Chronic Kidney Disease Diagnosis and Management
2019 Standout
Association of Novel Biomarkers of Cardiovascular Stress With Left Ventricular Hypertrophy and Dysfunction: Implications for Screening
2013
Prognostic Utility of ST2 in Patients with Acute Dyspnea and Preserved Left Ventricular Ejection Fraction
2011
Evaluation and Management of Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2012 Clinical Practice Guideline
2013 Standout
Clinical Utility of Pleural Fluid NT-pro Brain Natriuretic Peptide (NT-proBNP) in Patients with Pleural Effusions
2008
Transcatheter Mitral-Valve Repair in Patients with Heart Failure
2018 Standout
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
2017 Standout
Admission, Discharge, or Change in B-Type Natriuretic Peptide and Long-Term Outcomes
2011
Human and Animal Dirofilariasis: the Emergence of a Zoonotic Mosaic
2012 Standout
Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus
2016 Standout
Nitrile-Containing Pharmaceuticals: Efficacious Roles of the Nitrile Pharmacophore
2010 Standout
Clinical Policy: Critical Issues in the Evaluation and Management of Adult Patients Presenting to the Emergency Department with Acute Heart Failure Syndromes
2007
Diabetic Cardiomyopathy
2018 Standout
Clinical effectiveness and cost-effectiveness of clopidogrel and modified-release dipyridamole in the secondary prevention of occlusive vascular events: a systematic review and economic evaluation
2004
Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation
2004
Screening for hyperglycaemia in pregnancy: a rapid update for the National Screening Committee
2010 StandoutNobel
High diagnostic accuracy of NT-proBNP for cardiac origin of pleural effusions
2006
Epidemiology of Peripheral Artery Disease
2015 Standout
The Biological Basis for Cardiac Repair After Myocardial Infarction
2016 Standout
Growth Differentiation Factor 15 as a Biomarker in Cardiovascular Disease
2016
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
2020 Standout
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
2015 Standout
Particulate Matter Air Pollution and Cardiovascular Disease
2010 Standout
Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
2011 StandoutNobel
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Endocrine Treatment of Gender-Dysphoric/Gender-Incongruent Persons: An Endocrine Society* Clinical Practice Guideline
2017 Standout
Risk Factors for Progression of Peripheral Arterial Disease in Large and Small Vessels
2006
Basic Science Review: The Myopathy of Peripheral Arterial Occlusive Disease: Part 2. Oxidative Stress, Neuropathy, and Shift in Muscle Fiber Type
2008
Biomarkers of Cardiovascular Stress and Incident Chronic Kidney Disease
2013
Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
2018 Standout
Prognostic Utility of Novel Biomarkers of Cardiovascular Stress
2012
Effects of Disturbed Flow on Vascular Endothelium: Pathophysiological Basis and Clinical Perspectives
2011 Standout
Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
2012
ST2 and Multimarker Testing in Acute Decompensated Heart Failure
2015
Works of Thomas Mueller being referenced
Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure
2005
Characteristics of the Novel Interleukin Family Biomarker ST2 in Patients With Acute Heart Failure
2008
Serum total 8-iso-prostaglandin F2α: A new and independent predictor of peripheral arterial disease
2004
Plasma B-Type Natriuretic Peptide in Patients With Pleural Effusions
2005
Monitoring Aspirin 1 00 mg and Clopidogrel 75 mg Therapy with the PFA-1 00 Device in Patients with Peripheral Arterial Disease
2003
Relation between homocysteine and non‐fatal stroke in peripheral arterial disease
2002
Usefulness of Soluble Concentrations of Interleukin Family Member ST2 as Predictor of Mortality in Patients With Acutely Decompensated Heart Failure Relative to Left Ventricular Ejection Fraction
2011
Independent and incremental prognostic value of multimarker testing in acute dyspnea: Results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) study
2008
Prognostic value of increased adiponectin plasma concentrations in patients with acute destabilized heart failure
2009
Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases
2015
Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP) in frozen plasma samples
2004
Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma — The Presage™ ST2 assay
2009
Levosimendan infusion improves haemodynamics in elderly heart failure patients undergoing urgent hip fracture repair
2008
Pro-A-type natriuretic peptide and pro-adrenomedullin predict progression of chronic kidney disease: the MMKD Study
2008
Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate® analyzer—comparison with two flow cytometric methods
2007
B-type natriuretic peptide and amino terminal proBNP predict one-year mortality in short of breath patients independently of the baseline diagnosis of acute destabilized heart failure
2006
Biochemical diagnosis of impaired left ventricular ejection fraction - comparison of the diagnostic accuracy of brain natriuretic peptide (BNP) and amino terminal proBNP (NT-proBNP)
2004
Head-to-head comparison of the diagnostic utility of BNP and NT-proBNP in symptomatic and asymptomatic structural heart disease
2004
Soluble ST2 is not independently associated with androgen and estrogen status in healthy males and females
2011
The Presage®ST2 Assay: analytical considerations and clinical applications for a high-sensitivity assay for measurement of soluble ST2
2012
Prognostic value of established and novel biomarkers in patients with shortness of breath attending an emergency department
2010
Comparative Evaluation of B-Type Natriuretic Peptide, Mid-Regional Pro-A-type Natriuretic Peptide, Mid-Regional Pro-Adrenomedullin, and Copeptin to Predict 1-Year Mortality in Patients With Acute Destabilized Heart Failure
2007
Value of adiponectin as predictor of 5-year all-cause mortality in patients with symptomatic peripheral arterial disease: Results from the Linz Peripheral Arterial Disease (LIPAD) study
2009
Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World
2013
Increased Plasma Concentrations of Soluble ST2 are Predictive for 1-Year Mortality in Patients with Acute Destabilized Heart Failure
2008
Comparison of the Biomedica NT-proBNP Enzyme Immunoassay and the Roche NT-proBNP Chemiluminescence Immunoassay: Implications for the Prediction of Symptomatic and Asymptomatic Structural Heart Disease
2003
Importance of Biomarkers for Long-Term Mortality Prediction in Acutely Dyspneic Patients
2010
Impact of atherosclerotic risk factors on the anatomical distribution of peripheral arterial disease.
2001
Long-term stability of soluble ST2 in frozen plasma samples
2010